Fecal Microbiota Transplantation from Overweight or Obese Donors in Cachectic Patients with Advanced Gastroesophageal Cancer: A Randomized, Double-blind, Placebo-Controlled, Phase II StudyNicolien C. de Clercq, Max Nieuwdorp, Tom van den Ende et al.|Clinical Cancer Research|2021Cited by 72
Intestinal and tumor microbiome analysis combined with metabolomics of the anti-PD-L1 phase II PERFECT trial for resectable esophageal adenocarcinoma.Nicolien C. de Clercq, Max Nieuwdorp, Tom van den Ende et al.|Journal of Clinical Oncology|2020Cited by 1
Figure S1. from Fecal Microbiota Transplantation from Overweight or Obese Donors in Cachectic Patients with Advanced Gastroesophageal Cancer: A Randomized, Double-blind, Placebo-Controlled, Phase II StudyNicolien C. de Clercq, Max Nieuwdorp, Tom van den Ende et al.|Unknown|2023Cited by 0
Supplemental Materials from Fecal Microbiota Transplantation from Overweight or Obese Donors in Cachectic Patients with Advanced Gastroesophageal Cancer: A Randomized, Double-blind, Placebo-Controlled, Phase II StudyNicolien C. de Clercq, Max Nieuwdorp, Tom van den Ende et al.|Unknown|2023Cited by 0
Figure S2. from Fecal Microbiota Transplantation from Overweight or Obese Donors in Cachectic Patients with Advanced Gastroesophageal Cancer: A Randomized, Double-blind, Placebo-Controlled, Phase II StudyNicolien C. de Clercq, Max Nieuwdorp, Tom van den Ende et al.|Unknown|2023Cited by 0